SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001818382-24-000067
Filing Date
2024-05-21
Accepted
2024-05-21 16:08:57
Documents
1
Period of Report
2024-05-20

Document Format Files

Seq Description Document Type Size
1 FORM 4 wk-form4_1716322124.html 4  
1 FORM 4 wk-form4_1716322124.xml 4 5260
  Complete submission text file 0001818382-24-000067.txt   6800
Mailing Address 2525 EAST NORTH CAROLINA HIGHWAY 54 DURHAM NC 27713
Business Address 2525 EAST NORTH CAROLINA HIGHWAY 54 DURHAM NC 27713 919-313-9633
Humacyte, Inc. (Issuer) CIK: 0001818382 (see all company filings)

IRS No.: 851763759 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)

Mailing Address 210 WEST TRYON STREET HILLSBOROUGH NC 27278
Business Address
Wallace Max N. (Reporting) CIK: 0001877453 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-39532 | Film No.: 24969391